William V. Williams - 23 Dec 2022 Form 4 Insider Report for BriaCell Therapeutics Corp. (BCTX)

Role: President, CEO, Director
Signature: /s/ William V. Williams
Issuer symbol: BCTX
Transactions as of: 23 Dec 2022
Transactions value $: $4,908
Form type: 4
Filing time: 28 Dec 2022, 14:22:52 UTC
Previous filing: 01 Aug 2022
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BCTX	Warrant	Purchase	$4,908	+2,530	+9.28%	$1.94	29,802	23 Dec 2022	Common Shares	2,530	$5.31	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 8 is a weighted average price. These Warrants were purchased in multiple transactions at prices ranging from $1.97 to $2.00 per Warrant, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Warrants purchased at each separate price within the ranges set forth herein.

Content

The price reported in Column 8 is a weighted average price. These Warrants were purchased in multiple transactions at prices ranging from $1.97 to $2.00 per Warrant, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Warrants purchased at each separate price within the ranges set forth herein.